Literature DB >> 1732010

Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia.

J H Butterfield1, K M Leiferman, J Abrams, J E Silver, J Bower, N Gonchoroff, G J Gleich.   

Abstract

The syndrome of episodic angioedema and eosinophilia is characterized by cyclic edema, marked peripheral blood eosinophilia, and eosinophil degranulation in the dermis. Using a sensitive immunoenzymetric method, we measured serum interleukin (IL)-5 levels in four patients with this syndrome. We also determined the percentage of activated T cells in the peripheral blood of a new patient before and during an attack. In the patient presented, IL-5 levels peaked several days before maximal eosinophilia and then declined. This patient's lymphocytes showed an increased percentage, 28% (normal 2% to 3%), of activated T cells staining for both CD3 and HLA-DR 10 days before maximal eosinophilia, but no increase at the time of peak eosinophilia. In serum from three previously reported cases, elevated serum IL-5 levels were found during attacks. After glucocorticoid administration, IL-5 levels became undetectable in three of the four patients. Production of IL-5 is likely an important determinant of the pathophysiology of this syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1732010

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

2.  Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD).

Authors:  Bruce S Bochner; Wendy Book; William W Busse; Joseph Butterfield; Glenn T Furuta; Gerald J Gleich; Amy D Klion; James J Lee; Kristin M Leiferman; Michael Minnicozzi; Redwan Moqbel; Marc E Rothenberg; Lawrence B Schwartz; Hans-Uwe Simon; Michael E Wechsler; Peter F Weller
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

Review 3.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

Review 4.  Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract.

Authors:  Dagmar Simon; Andrew Wardlaw; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2010-04-14       Impact factor: 10.793

Review 5.  How I treat hypereosinophilic syndromes.

Authors:  Amy D Klion
Journal:  Blood       Date:  2015-05-11       Impact factor: 22.113

6.  Episodic angioedema with eosinophilia (Gleich syndrome) is a multilineage cell cycling disorder.

Authors:  Paneez Khoury; Jacqueline Herold; Alexandra Alpaugh; Ellen Dinerman; Nicole Holland-Thomas; Jennifer Stoddard; Shakuntala Gurprasad; Irina Maric; Olga Simakova; Lawrence B Schwartz; Juelia Fong; Chyi-Chia Richard Lee; Liqiang Xi; Zengfeng Wang; Mark Raffeld; Amy D Klion
Journal:  Haematologica       Date:  2014-12-19       Impact factor: 9.941

Review 7.  Novel Therapies for Eosinophilic Disorders.

Authors:  Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2015-08       Impact factor: 3.479

8.  IL-5 in post-traumatic eosinophilic pleural effusion.

Authors:  L Schandené; B Namias; A Crusiaux; M Lybin; R Devos; T Velu; P Capel; R Bellens; M Goldman
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

9.  Development of eosinophilic endomyocardial disease in a patient with episodic angioedema and eosinophilia.

Authors:  Benjamin L Wright; Joseph H Butterfield; Kristin M Leiferman; Gerald J Gleich
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

Review 10.  Evaluation and differential diagnosis of marked, persistent eosinophilia.

Authors:  Thomas B Nutman
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.